Post-approval studies (Phase 4)Study completedNCT03910361
What this trial is testing
Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases
Who this might be right for
Type2 DiabetesNon-Alcoholic Fatty Liver Disease
Dong-A ST Co., Ltd. 51